could semaglutide GLP-1 diabetes drugs stop anxiety and depression worsening, study finds | Drugs Semaglutide | DirectMeds

Transparency and consistency are central to how we operate

Current UK regulatory position includes: Warnings and precautions regarding thyroid C-cell tumours based on animal data, with acknowledgement that human relevance is uncertain Advice regarding pancreatitis risk, with recommendations to discontinue if acute pancreatitis is suspected and not to restart if confirmed No restrictions based on general cancer risk, as human evidence does not support an increased overall malignancy risk Monitoring for gallbladder disease, which has been associated with GLP-1 receptor agonist use The Summary of Product Characteristics (SmPC) for each GLP-1 medicine includes detailed safety information that healthcare professionals should review before prescribing

Spinal schwannomas top the list of spine nerve sheath tumors

A total of 99 samples were obtained from the brains of eight individuals (Supplementary Tables 1 and 2), which were processed for MS

Compared with NNT 3P-MACE (based on the primary CV composite endpoint), the addition of all-cause hospitalization (ACH) in the time to first-event analysis reduces the counts of other fatal and non-fatal events, suggesting ACH is a precursor to more severe events